Biotech · Private company
EicOsis Human Health Inc.
Track this companyFree. Adds EicOsis Human Health Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- EC5026 oral tabletPhase 2 · Parkinson's Disease (PD)ClinicalTrials.gov · fetched Nov 12, 2026
- EC5026 oral capsulePhase 1 · Healthy AdultsClinicalTrials.gov · fetched Nov 12, 2026
- EC5026 oral tabletPhase 1 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- EC5026 oral tabletPhase 1 · Healthy AdultsClinicalTrials.gov · fetched Nov 12, 2026
- EC5026 oral tabletPhase 1 · Spinal Cord InjuriesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Renal Impairment Study for Oral EC5026PHASE1 · RECRUITING · started Jul 1, 2026ClinicalTrials.gov NCT07694544 · fetched Nov 12, 2026
- Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord InjuryPHASE1 · RECRUITING · started May 1, 2026ClinicalTrials.gov NCT06438471 · fetched Nov 12, 2026
- Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)PHASE1_PHASE2 · RECRUITING · started Nov 1, 2025ClinicalTrials.gov NCT07142044 · fetched Nov 12, 2026
- Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy SubjectsPHASE1 · COMPLETED · started Apr 30, 2021ClinicalTrials.gov NCT04908995 · fetched Nov 12, 2026
- Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)UNKNOWN · started Jul 1, 2020ClinicalTrials.gov NCT04452942 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy SubjectsPHASE1 · COMPLETED · started Dec 9, 2019ClinicalTrials.gov NCT04228302 · fetched Nov 12, 2026